Welcome to LookChem.com Sign In|Join Free

CAS

  • or

58569-55-4

Post Buying Request

58569-55-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58569-55-4 Usage

Uses

Endogenous opioid peptide that also functions as a growth factor on many cell types at a receptor that is distinct from the neuronal opioid receptors

Check Digit Verification of cas no

The CAS Registry Mumber 58569-55-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,5,6 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 58569-55:
(7*5)+(6*8)+(5*5)+(4*6)+(3*9)+(2*5)+(1*5)=174
174 % 10 = 4
So 58569-55-4 is a valid CAS Registry Number.
InChI:InChI=1/C27H35N5O7S/c1-40-12-11-21(27(38)39)32-26(37)22(14-17-5-3-2-4-6-17)31-24(35)16-29-23(34)15-30-25(36)20(28)13-18-7-9-19(33)10-8-18/h2-10,20-22,33H,11-16,28H2,1H3,(H,29,34)(H,30,36)(H,31,35)(H,32,37)(H,38,39)/t20-,21-,22-/m0/s1

58569-55-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[[2-[[2-[[2-[[2-amino-3-(4-hydroxyphenyl)propanoyl]amino]acetyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-4-methylsulfanylbutanoic acid

1.2 Other means of identification

Product number -
Other names MET-enkephalin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:58569-55-4 SDS

58569-55-4Synthetic route

(S)-2-{(S)-2-[2-(2-{(S)-3-[4-(4-Bromo-phenoxycarbonyloxy)-phenyl]-2-tert-butoxycarbonylamino-propionylamino}-acetylamino)-acetylamino]-3-phenyl-propionylamino}-4-methanesulfinyl-butyric acid

(S)-2-{(S)-2-[2-(2-{(S)-3-[4-(4-Bromo-phenoxycarbonyloxy)-phenyl]-2-tert-butoxycarbonylamino-propionylamino}-acetylamino)-acetylamino]-3-phenyl-propionylamino}-4-methanesulfinyl-butyric acid

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With p-cresol; dimethylsulfide; hydrogen fluoride at 0℃; for 1h;92%
boc-Tyr-Gly-Gly-Phe-Met-OH
59481-77-5

boc-Tyr-Gly-Gly-Phe-Met-OH

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With hydrogenchloride; acetic acid for 1h;90%
With hydrogenchloride In acetic acid for 0.5h;85%
Boc-Tyr-Gly-Gly-Phe-Met-OBut
82362-16-1

Boc-Tyr-Gly-Gly-Phe-Met-OBut

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With methyl-phenyl-thioether; trifluoroacetic acid for 1h; Ambient temperature;74%
C17H13NO10S2(2-)*2Na(1+)

C17H13NO10S2(2-)*2Na(1+)

C20H19NO10S3(2-)*2Na(1+)

C20H19NO10S3(2-)*2Na(1+)

C24H19NO10S2(2-)*2Na(1+)

C24H19NO10S2(2-)*2Na(1+)

C24H19NO11S2(2-)*2Na(1+)

C24H19NO11S2(2-)*2Na(1+)

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Stage #1: C20H19NO10S3(2-)*2Na(1+) With sodium hydrogencarbonate; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; ethyl cyanoglyoxylate-2-oxime In water; acetonitrile at 20℃; for 0.75h;
Stage #2: With ethanolamine In water for 0.166667h;
Stage #3: C17H13NO10S2(2-)*2Na(1+); C24H19NO10S2(2-)*2Na(1+); C24H19NO11S2(2-)*2Na(1+) Further stages;
63%
Boc-Tyr(Mtb)-Gly-Gly-Phe-Met-OMtb
129398-74-9

Boc-Tyr(Mtb)-Gly-Gly-Phe-Met-OMtb

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With 3,5-dimethylmethoxybenzene; ethane-1,2-dithiol; trifluoroacetic acid 1) 0 deg C, 120 min, 2) 20 deg C, 60 min;57%
Boc-Tyr(Cl2Bzl)-Gly-Gly-Phe-Met-OBzl
129398-68-1

Boc-Tyr(Cl2Bzl)-Gly-Gly-Phe-Met-OBzl

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; methyl-phenyl-thioether; ethane-1,2-dithiol; 3-methyl-phenol; trifluoroacetic acid at 0℃; for 1.5h;49%
N-(diphenylphosphinoyl)tyrosylglycylglycylphenylalanylmethionine
148715-90-6

N-(diphenylphosphinoyl)tyrosylglycylglycylphenylalanylmethionine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 6h;40%
Boc-Tyr(tert.-Bu)-Gly-Gly-Phe-Met
62530-43-2

Boc-Tyr(tert.-Bu)-Gly-Gly-Phe-Met

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With hydrogenchloride; ethane-1,2-dithiol; methoxybenzene In 1,4-dioxane for 1h; Ambient temperature; Yield given;
Z-Tyr(Bzl)-Gly-Gly-Phe-Met
74937-32-9

Z-Tyr(Bzl)-Gly-Gly-Phe-Met

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With methyl-phenyl-thioether In trifluoroacetic acid at 25℃; for 4h; Yield given;
methyl ester of N,O-di-t-butyloxycarbonyl-L-tyrosylglycylglycyl-L-phenylalanyl-L-methionine
81649-52-7

methyl ester of N,O-di-t-butyloxycarbonyl-L-tyrosylglycylglycyl-L-phenylalanyl-L-methionine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With hydrogenchloride; sodium hydroxide 1.) methanol, water, 4 h, 2.) AcOH, 45 min; Yield given. Multistep reaction;
Z-Tyr-Gly-Gly-Phe-Hcy(Bzl)-OBzl
97512-82-8

Z-Tyr-Gly-Gly-Phe-Hcy(Bzl)-OBzl

methyl iodide
74-88-4

methyl iodide

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With sodium 1.) NH3 liq., -70 deg C, 2.) hexane-NH3, -70 -> -25 deg C, 1 h; Yield given. Multistep reaction;
methionine-enkephalin sulfoxide
60283-51-4

methionine-enkephalin sulfoxide

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With ammonium iodide; dimethylsulfide In trifluoroacetic acid at 0℃;
BocMet-R, Boc-amino acids

BocMet-R, Boc-amino acids

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Yield given; Multistep reaction;
phospho-Tyr-Gly-Gly-Phe-Met-OH

phospho-Tyr-Gly-Gly-Phe-Met-OH

A

met-enkephalin
58569-55-4

met-enkephalin

B

O-phosphono-L-tyrosine
21820-51-9

O-phosphono-L-tyrosine

C

L-tyrosine
60-18-4

L-tyrosine

D

[des-tyr1]-methionine enkephalin
61370-88-5

[des-tyr1]-methionine enkephalin

Conditions
ConditionsYield
With aminopeptidase M (EC3.4.11.2); 2-amino-2-hydroxymethyl-1,3-propanediol at 37℃; for 1h; pH=7.02; Kinetics; Hydrolysis;
-enkephalyl-arg6-phe7

-enkephalyl-arg6-phe7

A

L-arginyl-L-phenylalanine
2047-13-4

L-arginyl-L-phenylalanine

B

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
With angiotensin I converting enzyme In various solvent(s) at 37℃; pH=7.75; Kinetics;
-enkephalyl-arg6-phe7

-enkephalyl-arg6-phe7

A

YG
673-08-5

YG

B

met-enkephalin
58569-55-4

met-enkephalin

C

tyrosylglycylglycine
21778-69-8

tyrosylglycylglycine

D

L-tyrosine
60-18-4

L-tyrosine

Conditions
ConditionsYield
With membrane fraction In various solvents at 37℃; for 1h; pH=7.4; Product distribution; Further Variations:; Reagents;
N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

Boc-Pro, Boc-Cys(Bzl), Boc-Asn NPE, Boc-Val

Boc-Pro, Boc-Cys(Bzl), Boc-Asn NPE, Boc-Val

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: NMM / dimethylformamide / 0.17 h / -15 °C
2: NMM / dimethylformamide / 20 h / -20 °C
3: 90 percent / 1.5 N HCl/AcOH
4: 97 percent / HOBt*H2O, NEt3 / dimethylformamide / 23 h
5: 95 percent / 1.5 N HCl/AcOH / 1 h
6: 90 percent / HOBt*H2O, NEt3, DCC / dimethylformamide / a) -5 deg C to 0 deg C, 1 h, b) 20 deg C, 24 h
7: 86 percent / 0.5 M NaOH / acetone / 1.5 h
8: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
Methyl ester of N-t-butyloxycarbonyl-L-phenylalanyl-L-methionine
40290-63-9

Methyl ester of N-t-butyloxycarbonyl-L-phenylalanyl-L-methionine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 90 percent / 1.5 N HCl/AcOH
2: 97 percent / HOBt*H2O, NEt3 / dimethylformamide / 23 h
3: 95 percent / 1.5 N HCl/AcOH / 1 h
4: 90 percent / HOBt*H2O, NEt3, DCC / dimethylformamide / a) -5 deg C to 0 deg C, 1 h, b) 20 deg C, 24 h
5: 86 percent / 0.5 M NaOH / acetone / 1.5 h
6: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
Multi-step reaction with 5 steps
1: 98 percent / 4 M HCl / dioxane / 0.75 h
2: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) THF, 24 h
3: 91 percent / 2 M HCl / acetic acid / 0.75 h
4: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) DMF, THF, 24 h
5: 1.) 2 M NaOH, 2.) 2M HCl / 1.) methanol, water, 4 h, 2.) AcOH, 45 min
View Scheme
Multi-step reaction with 8 steps
1: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl / 1.) room temp., 5 h, 2.) Et2O
2: 1) N-methylmorpholine, 1-β-naphthalenesulphonyloxybenzotriazole / 1) EtOAc, DMF, 1.5h 2) RT 12h
3: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
4: 1) N-methylmorpholine, 1-β-naphthalenesulphonyloxybenzotriazole / 1) EtOAc, DMF, 1.5h, 2) RT, 12h
5: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
6: 1) 1-β-naphthalenesulphonyloxybenzotriazole, 2) N-methylmorpholine / 1) EtOAc, 1.5h, DMF, RT, 2) RT, 15h
7: 92.23 percent / 2N NaOH / methanol; H2O / 1 h / Ambient temperature
8: 10percentHCl, C6H5OCH3, HS-(CH2)2-SH / dioxane / 1 h / Ambient temperature
View Scheme
methyl N-tert-butoxycarbonyl-L-tyrosyldiglycyl-L-phenylalanyl-L-methioninate
60566-44-1

methyl N-tert-butoxycarbonyl-L-tyrosyldiglycyl-L-phenylalanyl-L-methioninate

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 86 percent / 0.5 M NaOH / acetone / 1.5 h
2: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
N-tert-Butyloxycarbonyl-glycyl-glycyl-L-phenylalanyl-L-methionin-methylester
70035-45-9

N-tert-Butyloxycarbonyl-glycyl-glycyl-L-phenylalanyl-L-methionin-methylester

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 95 percent / 1.5 N HCl/AcOH / 1 h
2: 90 percent / HOBt*H2O, NEt3, DCC / dimethylformamide / a) -5 deg C to 0 deg C, 1 h, b) 20 deg C, 24 h
3: 86 percent / 0.5 M NaOH / acetone / 1.5 h
4: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
Multi-step reaction with 3 steps
1: 91 percent / 2 M HCl / acetic acid / 0.75 h
2: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) DMF, THF, 24 h
3: 1.) 2 M NaOH, 2.) 2M HCl / 1.) methanol, water, 4 h, 2.) AcOH, 45 min
View Scheme
Multi-step reaction with 4 steps
1: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
2: 1) 1-β-naphthalenesulphonyloxybenzotriazole, 2) N-methylmorpholine / 1) EtOAc, 1.5h, DMF, RT, 2) RT, 15h
3: 92.23 percent / 2N NaOH / methanol; H2O / 1 h / Ambient temperature
4: 10percentHCl, C6H5OCH3, HS-(CH2)2-SH / dioxane / 1 h / Ambient temperature
View Scheme
Boc-Phe-O-COO-isoBu
67729-36-6, 60398-40-5

Boc-Phe-O-COO-isoBu

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: NMM / dimethylformamide / 20 h / -20 °C
2: 90 percent / 1.5 N HCl/AcOH
3: 97 percent / HOBt*H2O, NEt3 / dimethylformamide / 23 h
4: 95 percent / 1.5 N HCl/AcOH / 1 h
5: 90 percent / HOBt*H2O, NEt3, DCC / dimethylformamide / a) -5 deg C to 0 deg C, 1 h, b) 20 deg C, 24 h
6: 86 percent / 0.5 M NaOH / acetone / 1.5 h
7: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
hydrochloride of methyl ester of glycylglycyl-L-phenylalanyl-L-methionine
70035-46-0

hydrochloride of methyl ester of glycylglycyl-L-phenylalanyl-L-methionine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 90 percent / HOBt*H2O, NEt3, DCC / dimethylformamide / a) -5 deg C to 0 deg C, 1 h, b) 20 deg C, 24 h
2: 86 percent / 0.5 M NaOH / acetone / 1.5 h
3: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
Multi-step reaction with 2 steps
1: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) DMF, THF, 24 h
2: 1.) 2 M NaOH, 2.) 2M HCl / 1.) methanol, water, 4 h, 2.) AcOH, 45 min
View Scheme
Multi-step reaction with 3 steps
1: N-methylmorpholine, 2,6-luditine / CH2Cl2; dimethylformamide / 1.) 0 deg C, 1 h, 2.) r. t., 1 h
2: 91 percent / aq. NaOH / dimethylformamide / 6 h
3: 40 percent / aq. HCl / dioxane / 6 h
View Scheme
Multi-step reaction with 3 steps
1: 1) 1-β-naphthalenesulphonyloxybenzotriazole, 2) N-methylmorpholine / 1) EtOAc, 1.5h, DMF, RT, 2) RT, 15h
2: 92.23 percent / 2N NaOH / methanol; H2O / 1 h / Ambient temperature
3: 10percentHCl, C6H5OCH3, HS-(CH2)2-SH / dioxane / 1 h / Ambient temperature
View Scheme
L-phenylalaninyl-L-methionine methyl ether p-toluenesulfonate

L-phenylalaninyl-L-methionine methyl ether p-toluenesulfonate

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 97 percent / HOBt*H2O, NEt3 / dimethylformamide / 23 h
2: 95 percent / 1.5 N HCl/AcOH / 1 h
3: 90 percent / HOBt*H2O, NEt3, DCC / dimethylformamide / a) -5 deg C to 0 deg C, 1 h, b) 20 deg C, 24 h
4: 86 percent / 0.5 M NaOH / acetone / 1.5 h
5: 90 percent / 1.3 M HCl/AcOH / 1 h
View Scheme
N-tert-butoxycarbonyl-L-phenylalanine
13734-34-4

N-tert-butoxycarbonyl-L-phenylalanine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 90 percent / N,N'-dicyclohexylcarbodiimide (DCCI) / tetrahydrofuran / Ambient temperature
2: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) THF, 24 h
3: 98 percent / 4 M HCl / dioxane / 0.75 h
4: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) THF, 24 h
5: 91 percent / 2 M HCl / acetic acid / 0.75 h
6: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) DMF, THF, 24 h
7: 1.) 2 M NaOH, 2.) 2M HCl / 1.) methanol, water, 4 h, 2.) AcOH, 45 min
View Scheme
Multi-step reaction with 4 steps
1: 1.) N-methylmorpholine, isobutyl chloroformate / 1.) THF, -15 deg C, 1 min, 2.) -10 deg C, 30 min; 20 deg C, 2 h
2: 95 percent / 4.1 M HCl / dioxane / 4 h / 20 °C
3: 1.) 4.1 M HCl, isopentyl nitrite, 2.) Et3N / 1.) DMF, -20 deg C, 1 h, 2.) -30 deg C, 1 h; 4 deg C, 21 h
4: 1.) Na / 1.) NH3 liq., -70 deg C, 2.) hexane-NH3, -70 -> -25 deg C, 1 h
View Scheme
Multi-step reaction with 9 steps
1: 1)N-methylmorpholine, 1-β-napthalenesulphonyloxybenzotriazole / 1)EtOAc, RT, 1.5h 2) 12h RT
2: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl / 1.) room temp., 5 h, 2.) Et2O
3: 1) N-methylmorpholine, 1-β-naphthalenesulphonyloxybenzotriazole / 1) EtOAc, DMF, 1.5h 2) RT 12h
4: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
5: 1) N-methylmorpholine, 1-β-naphthalenesulphonyloxybenzotriazole / 1) EtOAc, DMF, 1.5h, 2) RT, 12h
6: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
7: 1) 1-β-naphthalenesulphonyloxybenzotriazole, 2) N-methylmorpholine / 1) EtOAc, 1.5h, DMF, RT, 2) RT, 15h
8: 92.23 percent / 2N NaOH / methanol; H2O / 1 h / Ambient temperature
9: 10percentHCl, C6H5OCH3, HS-(CH2)2-SH / dioxane / 1 h / Ambient temperature
View Scheme
Multi-step reaction with 8 steps
1.1: N,N-dimethyl-formamide / 20 °C
2.1: 4-methyl-morpholine / N,N-dimethyl-formamide / 0 °C / pH 7
2.2: 4 h / 0 - 20 °C
3.1: hydrogenchloride; methyl-phenyl-thioether; 2-hydroxyethanethiol / 1,4-dioxane / 0.25 h / 20 °C
4.1: 4-methyl-morpholine / N,N-dimethyl-formamide / 0 °C / pH 7
4.2: 0 °C
4.3: 4 h / 0 - 20 °C
5.1: hydrogenchloride; methyl-phenyl-thioether; 2-hydroxyethanethiol / 1,4-dioxane / 1 h / 20 °C
6.1: 4-methyl-morpholine / N,N-dimethyl-formamide / 0 °C
6.3: 4 h / 0 - 20 °C
7.1: palladium 10% on activated carbon / methanol / 0.33 h / 20 °C
8.1: hydrogenchloride; methyl-phenyl-thioether; 2-hydroxyethanethiol / 1,4-dioxane / 0.5 h / 0 °C
View Scheme
hydrochloride of methyl ester of L-phenylalanyl-L-methionine
40290-65-1

hydrochloride of methyl ester of L-phenylalanyl-L-methionine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) THF, 24 h
2: 91 percent / 2 M HCl / acetic acid / 0.75 h
3: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) DMF, THF, 24 h
4: 1.) 2 M NaOH, 2.) 2M HCl / 1.) methanol, water, 4 h, 2.) AcOH, 45 min
View Scheme
Multi-step reaction with 7 steps
1: 1) N-methylmorpholine, 1-β-naphthalenesulphonyloxybenzotriazole / 1) EtOAc, DMF, 1.5h 2) RT 12h
2: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
3: 1) N-methylmorpholine, 1-β-naphthalenesulphonyloxybenzotriazole / 1) EtOAc, DMF, 1.5h, 2) RT, 12h
4: 1.) HCO2H, PhOMe, HS-(CH2)2-SH, 2.) HCl
5: 1) 1-β-naphthalenesulphonyloxybenzotriazole, 2) N-methylmorpholine / 1) EtOAc, 1.5h, DMF, RT, 2) RT, 15h
6: 92.23 percent / 2N NaOH / methanol; H2O / 1 h / Ambient temperature
7: 10percentHCl, C6H5OCH3, HS-(CH2)2-SH / dioxane / 1 h / Ambient temperature
View Scheme
O-(t-butyloxycarbonyl-L-phenylalanyl)-2-pyridylmethylketoxime
81638-94-0

O-(t-butyloxycarbonyl-L-phenylalanyl)-2-pyridylmethylketoxime

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) THF, 24 h
2: 98 percent / 4 M HCl / dioxane / 0.75 h
3: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) THF, 24 h
4: 91 percent / 2 M HCl / acetic acid / 0.75 h
5: 1.) NH3, 2.) AcOH / 1.) CHCl3, 5 min, 2.) DMF, THF, 24 h
6: 1.) 2 M NaOH, 2.) 2M HCl / 1.) methanol, water, 4 h, 2.) AcOH, 45 min
View Scheme
N-benzyloxycarbonyl-O-benzyl-L-tyrosine
86827-18-1, 92455-53-3, 16677-29-5

N-benzyloxycarbonyl-O-benzyl-L-tyrosine

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: dicyclohexylcarbodi-imide
4: thioanisole / trifluoroacetic acid / 4 h / 25 °C
View Scheme
N-(O-benzyl-N-benzyloxycarbonyl-L-tyrosyl)-glycine ethyl ester
21869-36-3

N-(O-benzyl-N-benzyloxycarbonyl-L-tyrosyl)-glycine ethyl ester

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
3: thioanisole / trifluoroacetic acid / 4 h / 25 °C
View Scheme
Z-Tyr(Bzl)-Gly-N2H3
74916-75-9

Z-Tyr(Bzl)-Gly-N2H3

met-enkephalin
58569-55-4

met-enkephalin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
2: thioanisole / trifluoroacetic acid / 4 h / 25 °C
View Scheme
fluorescein isothiocyanate
3326-32-7, 27072-45-3

fluorescein isothiocyanate

met-enkephalin
58569-55-4

met-enkephalin

C48H46N6O12S2

C48H46N6O12S2

Conditions
ConditionsYield
With N-ethylmorpholine; In N,N-dimethyl-formamide at 20℃; for 24h;

58569-55-4Relevant articles and documents

Neutrophil-mediated oxidation of enkephalins via myeloperoxidase-dependent addition of superoxide

Nagy, Péter,Kettle, Anthony J.,Winterbourn, Christine C.

, p. 792 - 799 (2010)

Neutrophils play a major role in acute inflammation in part by generating superoxide and an array of other reactive species. These white blood cells also contribute to protection against inflammatory pain by releasing opioid peptides. The biochemical interactions of enkephalins with neutrophil-derived oxidants are not well understood. In this investigation we reveal that neutrophils use myeloperoxidase to oxidize enkephalins to their corresponding tyrosyl free radicals, which react preferentially with the superoxide to form a hydroperoxide. In methionine enkephalin, rapid intramolecular oxygen transfer from the hydroperoxide to the Met sulfur results in the formation of a sulfoxide derivative. This reaction may occur at sites of inflammation where enkephalins are released and neutrophils generate large amounts of superoxide. Hydroperoxide formation destroys the aromatic character of the Tyr residue by forming a bicyclic structure via conjugate addition of the terminal amine to the phenol ring. As the N-terminal Tyr and its amino group are essential for their opiate activity, we hypothesize that oxidative modification of this residue should affect the analgesic activity of enkephalins.

Sustainable Peptide Synthesis Enabled by a Transient Protecting Group

Avrutina, Olga,Knauer, Sascha,Koch, Niklas,Kolmar, Harald,Meusinger, Reinhard,Uth, Christina

supporting information, p. 12984 - 12990 (2020/06/01)

The growing interest in synthetic peptides has prompted the development of viable methods for their sustainable production. Currently, large amounts of toxic solvents are required for peptide assembly from protected building blocks, and switching to water as a reaction medium remains a major hurdle in peptide chemistry. We report an aqueous solid-phase peptide synthesis strategy that is based on a water-compatible 2,7-disulfo-9-fluorenylmethoxycarbonyl (Smoc) protecting group. This approach enables peptide assembly under aqueous conditions, real-time monitoring of building block coupling, and efficient postsynthetic purification. The procedure for the synthesis of all natural and several non-natural Smoc-protected amino acids is described, as well as the assembly of 22 peptide sequences and the fundamental issues of SPPS, including the protecting group strategy, coupling and cleavage efficiency, stability under aqueous conditions, and crucial side reactions.

Nicotinoyl peptide derivatives and cosmetic composition comprising the same

-

, (2012/03/11)

The present invention relates to nicotinoyl peptide derivatives, wherein neuropeptides are connected to nicotinic acid, and a cosmetic composition comprising the same. The peptide derivatives according to the present invention have good collagen generation and anti-inflammatory activities to show an excellent anti-wrinkle effect, little cytotoxicity, water-solubility, and good stability during long-term storage. Therefore, they can be effectively used for preparing an anti-aging cosmetic composition.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 58569-55-4